Lipid Profile Variations in Pregnancies with and without Cardiovascular Risk: Consequences for Both Mother and Newborn.

Simona-Alina Abu-Awwad, Marius Craina, Lioara Boscu, Elena Bernad, Paula Diana Ciordas, Catalin Marian, Mircea Iurciuc, Ahmed Abu-Awwad, Stela Iurciuc, Brenda Bernad, Diana Maria Anastasiu Popov, Anca Laura Maghiari
Author Information
  1. Simona-Alina Abu-Awwad: Doctoral School, "Victor Babes" University of Medicine and Pharmacy, 300041 Timisoara, Romania. ORCID
  2. Marius Craina: Clinic of Obstetrics and Gynecology, "Pius Brinzeu" County Clinical Emergency Hospital, 300723 Timisoara, Romania.
  3. Lioara Boscu: Doctoral School, "Victor Babes" University of Medicine and Pharmacy, 300041 Timisoara, Romania.
  4. Elena Bernad: Clinic of Obstetrics and Gynecology, "Pius Brinzeu" County Clinical Emergency Hospital, 300723 Timisoara, Romania. ORCID
  5. Paula Diana Ciordas: Departament IV-Discipline of Biochemistry, "Victor Babes" University of Medicine and Pharmacy, 300041 Timisoara, Romania.
  6. Catalin Marian: Departament IV-Discipline of Biochemistry, "Victor Babes" University of Medicine and Pharmacy, 300041 Timisoara, Romania. ORCID
  7. Mircea Iurciuc: Departament VI-Discipline of Outpatient Internal Medicine, Cardiovascular Prevention and Recovery, "Victor Babes" University of Medicine and Pharmacy, 300041 Timisoara, Romania.
  8. Ahmed Abu-Awwad: Department XV-Discipline of Orthopedics-Traumatology, "Victor Babes" University of Medicine and Pharmacy, 300041 Timisoara, Romania. ORCID
  9. Stela Iurciuc: Departament VI-Discipline of Outpatient Internal Medicine, Cardiovascular Prevention and Recovery, "Victor Babes" University of Medicine and Pharmacy, 300041 Timisoara, Romania.
  10. Brenda Bernad: Doctoral School, "Victor Babes" University of Medicine and Pharmacy, 300041 Timisoara, Romania.
  11. Diana Maria Anastasiu Popov: Diakonie Klinicum-Frauenklinik, 74523 Schwäbich Hall, Germany.
  12. Anca Laura Maghiari: Departament I-Discipline of Anatomy and Embryology, "Victor Babes" University of Medicine and Pharmacy, 300041 Timisoara, Romania.

Abstract

: Maternal cardiovascular risk and its implications can have significant repercussions for both the mother and the child. This study compares the lipid profiles of two distinct groups of pregnant women, those with and without cardiovascular risk, to shed light on its effects on maternal and outcomes for newborns. : This study enrolled 86 pregnant women, dividing them into two groups: Group 1 ( = 46, healthy pregnancies) and Group 2 ( = 40, pregnancies with cardiovascular risk factors). The data collected included maternal demographics, smoking history, pre-existing pathologies, and a range of laboratory measures. Neonatal outcomes were also recorded. : Group 2 showed a significant increase in the percentage of newborns with abnormal APGAR scores (-value < 0.0001), congenital abnormalities (-value < 0.0001), severe prematurity (-value < 0.0001), and neonatal mortality rates (-value < 0.0001), as well as differences in birth weight (-value = 0.0392) and therapy usage (surfactant: -value < 0.001, steroids -value = 0.004, and antibiotics -value < 0.001). Regarding laboratory measures, Group 2 exhibited significantly elevated levels of total cholesterol, LDL-C (-value < 0.0001), ApoB (-value < 0.0001), Lp(A) (-value = 0.0486), triglycerides (-value < 0.0001), and hs-CRP (-value = 0.0300). : These results underscore the elevated risk associated with pregnancies complicated by cardiovascular risk factors. Group 2 demonstrated a more concerning clinical profile, with a higher prevalence of detrimental neonatal outcomes and different lipid and inflammatory profiles, signifying a potential pathophysiological link. : The differential lipid profiles and adverse neonatal outcomes in pregnancies with cardiovascular risks highlight the urgency of effective risk stratification and management strategies in this population.

Keywords

References

  1. Circulation. 2019 Feb 19;139(8):1069-1079 [PMID: 30779636]
  2. Front Public Health. 2022 Jul 05;10:940335 [PMID: 35865249]
  3. J Clin Med. 2019 Oct 04;8(10): [PMID: 31590294]
  4. Am Heart J. 2004 Jul;148(1 Suppl):S19-26 [PMID: 15211329]
  5. Biomed Mater Eng. 2015;26 Suppl 1:S477-86 [PMID: 26406039]
  6. J Clin Endocrinol Metab. 2012 Nov;97(11):3917-25 [PMID: 22933545]
  7. Lipids Health Dis. 2020 Mar 16;19(1):42 [PMID: 32178672]
  8. J Am Coll Cardiol. 2016 Jul 26;68(4):396-410 [PMID: 27443437]
  9. Int J Pediatr. 2010;2010:401323 [PMID: 20981293]
  10. Hormones (Athens). 2015 Jul-Sep;14(3):345-57 [PMID: 26188222]
  11. Ethiop J Health Sci. 2019 Jan;29(1):831-840 [PMID: 30700950]
  12. Life Sci. 1995;56(26):2367-75 [PMID: 7791523]
  13. Endocrinology. 2021 Dec 1;162(12): [PMID: 34597389]
  14. BJOG. 2015 Apr;122(5):643-51 [PMID: 25612005]
  15. Am J Obstet Gynecol. 2019 Aug;221(2):150.e1-150.e13 [PMID: 30940559]
  16. Am J Epidemiol. 2014 Aug 15;180(4):346-58 [PMID: 24989239]
  17. Heliyon. 2022 Oct 14;8(10):e11098 [PMID: 36303922]
  18. Cardiovasc J Afr. 2016 Mar-Apr;27(2):89-94 [PMID: 27213856]
  19. J Am Coll Cardiol. 2013 Jul 30;62(5):397-408 [PMID: 23727085]
  20. Am Heart J. 2022 Mar;245:126-135 [PMID: 34902313]
  21. J Am Heart Assoc. 2019 Jan 8;8(1):e010440 [PMID: 30590966]
  22. PLoS Med. 2020 Jul 21;17(7):e1003183 [PMID: 32692751]
  23. Eur J Obstet Gynecol Reprod Biol. 2020 Mar;246:67-71 [PMID: 31962258]
  24. Int J Reprod Biomed. 2019 Nov 07;17(10):739-748 [PMID: 31807722]
  25. J Dev Orig Health Dis. 2021 Oct;12(5):738-747 [PMID: 33185172]
  26. J Taibah Univ Med Sci. 2021 Aug 09;16(6):870-877 [PMID: 34899132]
  27. Iran J Public Health. 2021 Jun;50(6):1266-1274 [PMID: 34540748]
  28. Methods Mol Biol. 2022;2508:115-134 [PMID: 35737237]
  29. Cureus. 2022 Sep 12;14(9):e29080 [PMID: 36249647]
  30. Indian J Med Res. 2015 Sep;142(3):261-8 [PMID: 26458341]
  31. Clin Chim Acta. 1999 Aug;286(1-2):115-43 [PMID: 10511288]

Word Cloud

Created with Highcharts 10.0.0-value0<risk0001cardiovascular=:outcomesGrouplipidpregnancies2neonatalprofilesmaternalfactorssignificantstudytwopregnantwomenwithouteffectsnewbornslaboratorymeasuresbirth001elevatedhealthMaternalimplicationscanrepercussionsmotherchildcomparesdistinctgroupsshedlightenrolled86dividinggroups:146healthy40datacollectedincludeddemographicssmokinghistorypre-existingpathologiesrangeNeonatalalsorecordedshowedincreasepercentageabnormalAPGARscorescongenitalabnormalitiessevereprematuritymortalityrateswelldifferencesweight0392therapyusagesurfactant:steroids004antibioticsRegardingexhibitedsignificantlylevelstotalcholesterolLDL-CApoBLp0486triglycerideshs-CRP0300resultsunderscoreassociatedcomplicateddemonstratedconcerningclinicalprofilehigherprevalencedetrimentaldifferentinflammatorysignifyingpotentialpathophysiologicallinkdifferentialadverseriskshighlighturgencyeffectivestratificationmanagementstrategiespopulationLipidProfileVariationsPregnanciesCardiovascularRisk:ConsequencesMotherNewbornmetabolismdisordersmaternal–fetalexchangepregnancyprenatalexposuredelayed

Similar Articles

Cited By